Tyratech (DI) Share Discussion Threads

[michaelsadvfn] 05/2/2016 12:23

Nobby,

These guys were responsible for the success of Merial's Frontline, they will be after a slice of that market sooner or later.

[nobbygnome] 05/2/2016 11:57

Thanks very much Timbo for the report and link to the slides. I don't think they have mentioned the products for pets before; at least it was news to me! This clearly is a massive potential market and as we know pet owners often look after their darlings better than themselves!

The other key issue is the fact they are well funded and have a path to profitability. The most frequentl issue with these small AIM stocks is the spectre of further fund raisings. If there really is no foreseeable reason for the requirement for more cash, then there is little to hold the price back. Clearly as has been discussed recently, there may be a short term stock overhang but once that has cleared I am very optimistic of substantial gains here. Indeed the overhang gives us all the opportunity to load up at what is an artificially depressed (by the overhang) price IMHO.

GLA

Nobby

[timbo003] 05/2/2016 11:10

The slide set used for Tuesday's presentation is now available, see active link below.

The video of the presentation will be made available later today (apparently)

[michaelsadvfn] 05/2/2016 08:06

timbo,

We are where we are due to 2 things, the first was this statement in the half-yearly report...

Sales have continued to grow in absolute terms during the period since 30 June. However, they have been behind our forecast expectations and if this trend continues for the remainder of the year, our second half results, whilst still expected to be materially better than the first half, will not be as strong as previously thought.

The second, obviously, was the November placing at 3p.

Recent comment has suggested they will only marginally miss the 2015 analysts targets...

Whilst total revenues for the year are expected to be marginally lower than expected...

Based on those statements it seems to me the final quarter of 2015 may have been a good one. The prelims on 7th April could provide the catalyst for a move higher.

[timbo003] 04/2/2016 11:19

>>>>m-adfvn

Overall I was quite reassured, the shares do seem cheap on a fundamental basis given the market cap of around £10M. If they do reach profitability without further fund raising then the shares are likely to be quite a bit higher than they are now. However, I suspect they will stay down at these levels for a while yet though due to the apparent overhang which is presumably from L&G (and perhaps others) who either doubt the forecast, or now find that Tyratech no longer fits in with their investment remit for whatever reason.

[michaelsadvfn] 04/2/2016 08:52

Thanks for the feedback timbo003, much appreciated.

[timbo003] 03/2/2016 17:59

Tyratech were at the Innovators & Investors Forum yesterday


In addition to a stand at the show, Bruno Jactel (CEO) gave a short 15 minute presentation on the company, the time was strictly controlled and there was no time allocated for questions (for any of the speakers).

I was told by one of the shows organisers that the slide sets used for all presentations should appear on the Shares Mag events web site later this week and videos of the presentations should appear a day or two later.

Bruno gave a succinct overview of the company, its products and prospects. He began with Vamouse and described in layman’s terms:

* What it is: a proprietary formulation(s) using Nature’s Technology ™ to control head lice utilising established safe ingredients with gernaniol as the principal active ingredient
* How it works: two (consecutive) modes of action, firstly by dissolving the insect’s exoskeleton and secondly by penetrating through the compromised exoskeleton and into the insect’s abdomen causing osmotic stress and rupture of the insect’s gut. There was a gory movie that showed a semi translucent insect that had been immobilised on a microscope slide having an internal haemorrhage following treatment with Vamousse.
* How it’s protected: The technology used for Vamousse and other Tyrotech products is covered by 30 granted patents with a further 30 patents pending
* Where it is sold: US and UK (multiple major retail outlets).


Bruno went on to describe how they have developed the technology for other applications for human use (for example Guardian Insect repellent) and for animal applications: initially for Poultry (Pure Science) and then for horses (Outsmart) , companion animals and meat production animals. Insecticides are mostly prohibited for poultry production (in the US) and insect infestations could reduce production efficiency for food production and are undesirable from an aesthetic perspective for egg production.

We were told that insects develop resistance to conventional pesticides and so regulatory agencies limit the number of pesticides available for food production. Furthermiore insects have developed resistance to the few that are permitted and there is always a risk of conventional insecticides entering the food chain, this is not an issue with Tyratec’s Nature’s technology based formulations which are considered safe and non-toxic to humans.

Bruno zoomed through the slides concerning potential market opportunity, so I have incomplete notes for this section, but he said that the Poultry market was worth $9Bn in the US and around $50Bn worldwide and the addressable market for insect control in the Tyratech’s target animals (poultry, companion, horse, food production) was $0.7Bn, 0.8Bn, 0.1Bn and 0.7Bn (need to see slides to confirm these numbers).

Going forward Tyratech will concentrate on three areas:
• Geographical expansion (for example, European roll out of Vamousse)
• Develop and progress product Pipeline
• Increase market penetration (expand distribution and increase market share)

Finally Bruno summed up by saying the company was now well funded with a well thought out road map to profitability



I also spent a bit of time at the Tyratech stand (see photo below from the shares mag photo gallery) where I spoke with Erica Boisvert (the new CFO) and Barry Riley (Non-exec director and until recently acting CFO) on various topics including the product range and technology, profit margins, brand value and EIS tax reliefs on shares from the most recent placing (in which I participated). It was good to hear it confirmed that the shares do qualify for EIS tax breaks, the company is debt free and they own the technology outright so no profit sapping royalties to pay out to any third party. Finally I managed to procure a couple of freebies at the stand: a quality ball point pen (green and white with a Tyratech decal) and a sample of Guardian ™ Backyard Mosquito and Tick repellent spray (as sold in the USA) which I intend to do a field trial in the Everglades on my next holiday to Florida.

[michaelsadvfn] 03/2/2016 14:10

2 years ago, almost to the day, Tyratech was trading at 6.5p when this Daily Mail article sent the shares to over 20p...



All that hard work getting Vamousse onto the shelves of 20,000 outlets in the USA, not to mention the UK, and you can now buy at half the price.

2015 sales will come in somewhere around the $9m mark and there's little chance of that figure falling in future years. Sales are growing fast.

I've recently upped my position to about 1% of the Company.

Far too cheap.

[michaelsadvfn] 03/2/2016 12:34

Buying @ 3.09p

[chinese investor] 03/2/2016 12:12

Whoosh Indeed !

[michaelsadvfn] 03/2/2016 09:55

Q.E.D......whoosh!!

[michaelsadvfn] 03/2/2016 09:42

Perhaps that overhang is about cleared; house broker has gone out to 3.5p offer from 3p after that 52k buy. Peel Hunt on 3p then 3.5p offer.

TYRU can move quickly....up as well as down!

[michaelsadvfn] 03/2/2016 08:34

Company website has been redesigned...

[nobbygnome] 02/2/2016 08:23

>> techair

It is probably a waste of time engaging in rational debate but here goes. The bull case is

1. Bombed out share price
2. Superb products with unique selling points
3. Management with good credentials (although I acknowledge that they need to prove themselves at TYR yet)
4. A director who is ready to put in his own money on a regular basis
5. A reasonable amount of cash to market and launch the products

Clearly the issue is the latter that they will never have enough money to market the products as well as they could. However, therein lies my point about the value of the Vamousse brand to a larger organisation with marketing muscle. To me this all clearly adds up to a big increase in the price from this level. There is the overhang from the fund raising to deal with first but once that is gone there is at least 100% to be made from this level and probably a lot more. You won't make that on GSK or other similar companies...

All IMHO of course.....

Nobby

[michaelsadvfn] 02/2/2016 07:10

techair,

Pathetic comment.

techair 1 Feb'16 - 20:31 - 267 of 267 0 1 (Filtered)

Muppet.

[techair] 01/2/2016 20:31

Good luck ramping this one

[nobbygnome] 01/2/2016 19:03

The mark down this morning was ridiculous and cost the MMs although a relatively small amount. Any miss in revenue was already built into the price big time so a very small miss should have been seen positively. I have already bought in big at these levels but may add a few more. The potential of the Vamousse brand means that this is clearly worth more than the entire market cap at present. As I said before it is all about marketing potential and the value to a company with cash to invest would be high.

At these levels the company is a no brainer in the medium term IMHO.

Nobby

[michaelsadvfn] 01/2/2016 13:38

Alan Reade buying again, can't complain about Directors not supporting the Company.

[al h] 01/2/2016 08:19

Proof if ever you want it that share price movements have little to do with trading. Monkey scum move prices as and how they feel like most of the time. So much for market forces ... total nonsense.

[michaelsadvfn] 01/2/2016 08:01

Not much in that update to tell us what's happening.

Having already been trashed due to not meeting expectations they might just trash the share price again on this statement for the same reason.

It may present an opportunity to buy some at a price I thought I'd never see...

They aren't very good at promoting themselves, that's quite clear.

Edit: took 100k @ 2.4999

[michaelsadvfn] 27/1/2016 09:07

As ever, as soon as the bid rises 0.25p in comes someone to bring it back down.

Dear me. Can't see this going up without some very good news.

[timbo003] 25/1/2016 21:11

I've just been sent a reminder regarding the Innovators & Investors Forum 2016 (Tuesday 2nd February 2016)



Tyratec will be there along with a number of other companies where I have an interest, so I will be going along and will report back here with any nuggets gleaned regarding current progress and prospects.

[nobbygnome] 20/1/2016 12:53

Yes indeed. The RNS today says something about a 'number of markets' soI am sure we will hear soon. This overhang gives a superb buying opportunity to the brave. Just snapped up another 50k at 3p via spread bet.

Regards

Nobby

[michaelsadvfn] 20/1/2016 12:02

Ta Nobby.

Must be about time they tell us what's happening with Germany/Australasia, almost 3 months have gone by since they raised funds to allow this expansion. While they're at it can we also have a review of 2015?

Ta Bruno.